Epidemic Spreading Model to Characterize Misfolded Proteins Propagation in Aging and Associated Neurodegenerative Disorders
暂无分享,去创建一个
Alan C. Evans | Yasser Iturria-Medina | Roberto C. Sotero | Paule-Joanne Toussaint | R. Sotero | Y. Iturria-Medina | P. Toussaint | Y. Iturria-medina
[1] D. Rubinsztein,et al. Autophagy and misfolded proteins in neurodegeneration , 2012, Experimental Neurology.
[2] J. Morris,et al. Alzheimer’s Disease: The Challenge of the Second Century , 2011, Science Translational Medicine.
[3] G. Sandini,et al. Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease. , 2009, Brain : a journal of neurology.
[4] Bradley T. Hyman,et al. Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta , 2013, Neuron.
[5] Thomas Wisniewski,et al. Immunotherapy for Alzheimer's disease. , 2014, Biochemical pharmacology.
[6] P. Lansbury,et al. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.
[7] Lester Melie-García,et al. Characterizing brain anatomical connections using diffusion weighted MRI and graph theory , 2007, NeuroImage.
[8] Sofia Nyström,et al. Erratum: Transmissibility of systemic amyloidosis by a prion-like mechanism (Proceedings of the National Academy of Sciences of the United States of America (May 14, 2002) 99: 10 (6979-6984)) , 2003 .
[9] Jose Viña,et al. Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[10] L. Mucke,et al. A network dysfunction perspective on neurodegenerative diseases , 2006, Nature.
[11] G. Landreth,et al. Evidence for impaired amyloid β clearance in Alzheimer's disease , 2013, Alzheimer's Research & Therapy.
[12] R. Petersen,et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.
[13] Noo Li Jeon,et al. β‐Amyloid is transmitted via neuronal connections along axonal membranes , 2014, Annals of neurology.
[14] C. Jack,et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.
[15] Hansjürgen Bratzke,et al. Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.
[16] Francis Eustache,et al. The Default Mode Network in Healthy Aging and Alzheimer's Disease , 2011, International journal of Alzheimer's disease.
[17] Tammie L. S. Benzinger,et al. Increased in Vivo Amyloid-β42 Production, Exchange, and Loss in Presenilin Mutation Carriers , 2013, Science Translational Medicine.
[18] Angel Ortega,et al. Gender and age-dependent differences in the mitochondrial apoptogenic pathway in Alzheimer's disease. , 2008, Free radical biology & medicine.
[19] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[20] Arno Klein,et al. 101 Labeled Brain Images and a Consistent Human Cortical Labeling Protocol , 2012, Front. Neurosci..
[21] R. Buckner,et al. Evidence for the Default Network's Role in Spontaneous Cognition , 2010 .
[22] D. Sharp,et al. The role of the posterior cingulate cortex in cognition and disease. , 2014, Brain : a journal of neurology.
[23] Ernesto Estrada,et al. Epidemic spreading in networks with nonrandom long-range interactions. , 2011, Physical review. E, Statistical, nonlinear, and soft matter physics.
[24] O. Sporns,et al. Network hubs in the human brain , 2013, Trends in Cognitive Sciences.
[25] E. Bullmore,et al. The hubs of the human connectome are generally implicated in the anatomy of brain disorders , 2014, Brain : a journal of neurology.
[26] Harry LeVine,et al. Corruption and Spread of Pathogenic Proteins in Neurodegenerative Diseases* , 2012, The Journal of Biological Chemistry.
[27] J. Snow. On the Mode of Communication of Cholera , 1856, Edinburgh medical journal.
[28] Mathias Jucker,et al. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases , 2013, Nature.
[29] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[30] Yasser Iturria-Medina,et al. Anatomical Brain Networks on the Prediction of Abnormal Brain States , 2013, Brain Connect..
[31] David M Holtzman,et al. Human Apoe Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance Nih Public Access , 2022 .
[32] J. Viña,et al. Aβ and tau toxicities in Alzheimer’s are linked via oxidative stress-induced p38 activation: Protective role of vitamin E , 2014, Redox biology.
[33] Jack Waters,et al. The Concentration of Soluble Extracellular Amyloid-β Protein in Acute Brain Slices from CRND8 Mice , 2010, PloS one.
[34] Ulrike Groemping,et al. Relative Importance for Linear Regression in R: The Package relaimpo , 2006 .
[35] P. Sen,et al. Introduction to bivariate and multivariate analysis , 1981 .
[36] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[37] Efstathios D. Gennatas,et al. Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome , 2012, Neuron.
[38] Jean-Michel Verdier,et al. Increased Amyloid-β Peptide-Induced Memory Deficits in Phospholipid Transfer Protein (PLTP) Gene Knockout Mice , 2013, Neuropsychopharmacology.
[39] Claudio Soto,et al. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission. , 2011, Seminars in cell & developmental biology.
[40] Jürgen Götz,et al. Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease , 2011, Nature Reviews Neuroscience.
[41] Bill Seeley,et al. Neurodegenerative diseases target large-scale human brain networks , 2010, Alzheimer's & Dementia.
[42] M. Diamond,et al. Propagation of Tau Misfolding from the Outside to the Inside of a Cell* , 2009, Journal of Biological Chemistry.
[43] Ronald Melki,et al. Prion-like transmission of protein aggregates in neurodegenerative diseases , 2010, Nature Reviews Molecular Cell Biology.
[44] J. Haines,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.
[45] B. Hyman,et al. The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide , 2010, PloS one.
[46] Sofia Nyström,et al. Transmissibility of systemic amyloidosis by a prion-like mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[47] Nick C Fox,et al. 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study , 2010, The Lancet Neurology.
[48] W. Jagust,et al. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core , 2010, Alzheimer's & Dementia.
[49] Mara Cercignani,et al. Twenty‐five pitfalls in the analysis of diffusion MRI data , 2010, NMR in biomedicine.
[50] L. Mucke,et al. Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks , 2010, Nature Neuroscience.
[51] Giovanni Coppola,et al. Gender Modulates the APOE ε4 Effect in Healthy Older Adults: Convergent Evidence from Functional Brain Connectivity and Spinal Fluid Tau Levels , 2012, The Journal of Neuroscience.
[52] Jeffrey A. James,et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. , 2008, Archives of neurology.
[53] Christopher M. Dobson,et al. Protein-misfolding diseases: Getting out of shape , 2002, Nature.
[54] Shaomin Li,et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.
[55] A. J. Lotka,et al. Elements of Physical Biology. , 1925, Nature.
[56] Cornelis J. Stam,et al. Activity Dependent Degeneration Explains Hub Vulnerability in Alzheimer's Disease , 2012, PLoS Comput. Biol..
[57] P. Bosco,et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance , 2011, Molecular Psychiatry.
[58] Robert A. Dean,et al. Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI , 2011, Acta Neuropathologica.
[59] Denise C. Park,et al. Beta-Amyloid Deposition and the Aging Brain , 2009, Neuropsychology Review.
[60] Scott A. Small,et al. Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis , 2008, Neuron.
[61] M. Viitanen,et al. Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease , 2008, Annals of neurology.
[62] Salvador Ventura,et al. Protein misfolding diseases , 2015, Future science OA.
[63] M. Weiner,et al. A Network Diffusion Model of Disease Progression in Dementia , 2012, Neuron.
[64] James Sayre,et al. MGAT3 mRNA: a biomarker for prognosis and therapy of Alzheimer's disease by vitamin D and curcuminoids. , 2011, Journal of Alzheimer's disease : JAD.
[65] J. Hardy,et al. Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.
[66] Donald A. Wilson,et al. ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models , 2012, Science.
[67] Fang-Cheng Yeh,et al. NTU-90: A high angular resolution brain atlas constructed by q-space diffeomorphic reconstruction , 2011, NeuroImage.
[68] A. Wallin,et al. Biomarkers in Relation to Cognitive Reserve in Patients with Mild Cognitive Impairment – Proof of Concept , 2009, Dementia and Geriatric Cognitive Disorders.
[69] Michael W. Weiner,et al. APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study , 2013, Molecular Psychiatry.
[70] Anders Wallin,et al. Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. , 2005, Clinical chemistry.
[71] K Herholz,et al. Metabolic interaction between ApoE genotype and onset age in Alzheimer’s disease: implications for brain reserve , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[72] Martin Ingelsson,et al. The Alzheimer's Disease-Associated Amyloid \(\beta\)-Protein Is an Antimicrobial Peptide , 2010 .
[73] Olaf Sporns,et al. Weight-conserving characterization of complex functional brain networks , 2011, NeuroImage.
[74] Steven Hou,et al. Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β. , 2012, Brain : a journal of neurology.
[75] Nick C Fox,et al. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.
[76] Arthur W. Toga,et al. A Probabilistic Atlas of the Human Brain: Theory and Rationale for Its Development The International Consortium for Brain Mapping (ICBM) , 1995, NeuroImage.
[77] J. Morris,et al. Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.
[78] D. Cui,et al. Acceleration of murine AA amyloidosis by oral administration of amyloid fibrils extracted from different species , 2002, Pathology international.
[79] Adam Douglass,et al. Mechanism of Prion Propagation: Amyloid Growth Occurs by Monomer Addition , 2004, PLoS biology.
[80] K. Abel,et al. Immune defects in Alzheimer's disease: new medications development , 2008, BMC Neuroscience.
[81] Martin Hallbeck,et al. Neuron-to-Neuron Transmission of Neurodegenerative Pathology , 2013, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[82] D. Selkoe,et al. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.
[83] Keith A. Johnson,et al. Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease , 2009, The Journal of Neuroscience.
[84] Leonore A. Herzenberg,et al. Reversal of Paralysis and Reduced Inflammation from Peripheral Administration of β-Amyloid in TH1 and TH17 Versions of Experimental Autoimmune Encephalomyelitis , 2012, Science Translational Medicine.
[85] Alan C. Evans. Networks of anatomical covariance , 2013, NeuroImage.
[86] M. Greicius,et al. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.
[87] D. Schacter,et al. The Brain's Default Network , 2008, Annals of the New York Academy of Sciences.
[88] Benjamin J. Shannon,et al. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.
[89] M. Fändrich,et al. The aggregation kinetics of Alzheimer's β‐amyloid peptide is controlled by stochastic nucleation , 2005, Protein science : a publication of the Protein Society.
[90] C. Dobson. Protein folding and misfolding , 2003, Nature.
[91] J. Haines,et al. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .
[92] A. J. Lotka. Elements of Physical Biology. , 1925, Nature.
[93] Martin Hallbeck,et al. Spreading of amyloid-β peptides via neuritic cell-to-cell transfer is dependent on insufficient cellular clearance , 2014, Neurobiology of Disease.
[94] Alan C. Evans,et al. An MRI-Based Probabilistic Atlas of Neuroanatomy , 1994 .
[95] D. Helbing,et al. The Hidden Geometry of Complex, Network-Driven Contagion Phenomena , 2013, Science.
[96] Edward T. Bullmore,et al. Whole-brain anatomical networks: Does the choice of nodes matter? , 2010, NeuroImage.
[97] Björn Granseth,et al. Spreading of Neurodegenerative Pathology via Neuron-to-Neuron Transmission of β-Amyloid , 2012, The Journal of Neuroscience.
[98] B. Strooper,et al. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.
[99] S. W. Davies,et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.
[100] H. Braak,et al. The Biphasic Relationship between Regional Brain Senile Plaque and Neurofibrillary Tangle Distributions: Modification by Age, Sex, and APOE Polymorphism , 2004, Annals of the New York Academy of Sciences.
[101] Simon B. Eickhoff,et al. Microstructural grey matter parcellation and its relevance for connectome analyses , 2013, NeuroImage.
[102] M. Diamond,et al. Prion-like mechanisms in neurodegenerative diseases , 2010, Nature Reviews Neuroscience.